First Time Loading...

Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 30.42 USD -1.33% Market Closed
Updated: May 7, 2024

Supernus Pharmaceuticals Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Supernus Pharmaceuticals Inc
Cash from Financing Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Cash from Financing Activities
-$397.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Financing Activities
-$21.4B
CAGR 3-Years
-46%
CAGR 5-Years
-3%
CAGR 10-Years
-10%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Financing Activities
$8.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Cash from Financing Activities
$26.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Cash from Financing Activities
-$4.8B
CAGR 3-Years
-12%
CAGR 5-Years
17%
CAGR 10-Years
-5%
Eli Lilly and Co
NYSE:LLY
Cash from Financing Activities
$2.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Supernus Pharmaceuticals Inc's Cash from Financing Activities?
Cash from Financing Activities
-397.9m USD

Based on the financial report for Dec 31, 2023, Supernus Pharmaceuticals Inc's Cash from Financing Activities amounts to -397.9m USD.

What is Supernus Pharmaceuticals Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-3 689%

Over the last year, the Cash from Financing Activities growth was -3 689%.